With a valuation of USD 1.67 billion in 2024, the global head and neck cancer therapeutics market is expected to expand at a CAGR of 11.2% during 2025–2034, reaching an estimated USD 4.32 billion. The surge in cancer cases and advancements in targeted therapies are key growth drivers. https://www.expertmarketresearch.com/reports/head-and-neck-cancer-therapeutics-market